Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.jvs.2011.07.068 | DOI Listing |
Ann Vasc Surg
November 2024
Department of Public Health, Vascular Surgery Unit, University Federico II of Naples, Naples, Italy.
Background: The AFX unibody endograft offers advantages in treating abdominal aortic aneurysms (AAAs) with narrow aortic bifurcations due to its unique design, where the flow divider sits at the native aortic bifurcation. However, its limited length options may limit complete proximal neck utilization. As per device instruction for use, the implant should be completed with an aortic cuff.
View Article and Find Full Text PDFJ Endovasc Ther
October 2024
Department of Vascular and Cardiothoracic Surgery, University of Göttingen, Göttingen, Germany.
Cureus
August 2024
Cardiovascular Surgery, Sapporo Medical University, Sapporo, JPN.
Surgical treatment of infected aneurysms is problematic due to their high complication and mortality rates. Infected aortic aneurysms are at high risk of rupture and should be operated on as soon as possible after diagnosis. A 72-year-old female patient with a medical history of diabetes mellitus, hyperlipidemia, and hypertension presented with a fever of 38°C and back pain, without any apparent cause, in 2021.
View Article and Find Full Text PDFJ Clin Med
September 2024
Department of Vascular Surgery, Larissa University Hospital, Faculty of Medicine, University of Thessaly, 41110 Larissa, Greece.
J Endovasc Ther
August 2024
Division of Vascular and Endovascular Surgery, Hospital do Servidor Público Estadual de São Paulo, São Paulo, Brazil.
Objective: The main objective of this paper is to analyze the outcomes regarding endoleaks, reinterventions, and death related to aneurysm complications in patients submitted to endovascular repair (EVAR) for abdominal aortoiliac aneurysm (AAA) using Endurant II (Medtronic) and Zenith Flex (Cook) endografts.
Methods: This was a prospective, consecutive cohort study of patients with AAA who underwent EVAR between January 2019 and December 2022. Two groups of patients were evaluated: Group Endurant (patients submitted to EVAR with the use of Endurant II) and Group Zenith (patients submitted to EVAR with the use of Zenith Flex).
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!